Santa Monica-based ketamine infusion clinic Kure has officially opened a Santa Monica outpost at 2730 Wilshire Blvd. The clinic uses ketamine therapy to treat mental health conditions.
“As someone who has been surveying the quality of specialty surgery centers for seven years, I’m taking what extensive safety principals I’ve learned and applying them to how we treat patients here at Kure,” Dr. Steve Yun, medical director of Kure and a safety inspector for the American Association for Accreditation of Ambulatory Surgery Facilities, said in a statement. “Our staff are trained in advanced cardiovascular life support, specialize in psychiatry, and have backgrounds in emergency medicine and various clinical fields to ensure prompt intervention in the rare case it’s ever needed.”
Kure was founded in 2022. The company plans to expand and is currently considering additional locations. It uses ketmaine to help treat anxiety, depression, PTSD, chronic migraines, sciatica pain and more. Ketamine can be used for dissociative anesthesia in children, adolescents and young adults and is used by some as a method of sedation.
Kure isn’t the only company to open a ketamine clinic in L.A. lately.
Last year Pasithea Clinics, a subsidiary of Miami-based biotech firm Pasithea Therapeutics, opened a West Hollywood clinic on Sunset Boulevard.
Pasithea Clinics has four treatment rooms and a team of health care providers. It uses intravenous ketamine for the treatment of depression and post-traumatic stress disorder.
“My main goal in life is to provide new solutions for patients needing help with the mental health challenges they are facing,” Dr. Tiago Marques, the chief executive and co-founder of Pasithea, said in a statement at the time. “Pasithea is innovating the way we treat psychiatric disorders and the opening of our Los Angeles clinic is the next step in revolutionizing care for those who are suffering.”
Other ketamine clinics have been opening in Los Angeles and worldwide.
The global ketamine treatment market was valued at $132 million in 2021 and is expected to rise to $3.9 billion by 2027, according to a report from Market Reports World.
The increasingly popular drug is a rapid-acting antidepressant but also can produce some psychedelic effects and has been taken recreationally. In recent years thousands of patients have undergone legal therapy as hundreds of ketamine clinics have opened.
But the quickly growing industry is having growing pains. Last week, the Ketamine Wellness Clinics, with locations in nine states but not California, reportedly shut down. But it had a post on its website saying a pending acquisition could result in the clinics being reopened soon.
Source: Hannah Madans Welk, Los Angeles Business Journal